Last reviewed · How we verify
NCT04969380
SofWave Treatment to Lift Lax Tissue in the Submental and Neck Zones and to Lift the Eyebrow
NA trial testing Sofwave in Skin Laxity in 20 participants. Completed in 27 February 2023.
27 February 2023
Quick facts
| Lead sponsor | Sofwave Medical LTD |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 20 |
| Start date | 27 February 2020 |
| Primary completion | 27 February 2023 |
| Estimated completion | 27 February 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Sofwave
Conditions studied
- Skin Laxity — all drugs for Skin Laxity →
Sponsor
Sofwave Medical LTD
Who can join
Adults 35 to 80, any sex, with Skin Laxity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Open-label, non-randomized, prospective, multi-center, self-controlled clinical study with masked evaluation.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04969380
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Sofwave
Trials testing the same drug.
- NCT07342452 — Randomized Trial of Combination Treatment With Sofwave and Sculptra · Phase 4 · not yet recruiting
- NCT06333067 — Treatment to Lift Facial Lax Skin and Improve Facial Wrinkles Using Precise and Lift Applicators · NA · recruiting
- NCT06104514 — Safety and Efficacy of SofWave Treatment to Lift the Upper Lip and Improve the Peri-Oral Rhytids · NA · completed
- NCT05882721 — Treatment for Improvement of Cellulite Appearance Using Form Applicator · NA · completed
- NCT05358327 — Treatment for Lifting Upper Arm Lax Skin · NA · completed
Other recruiting trials for Skin Laxity
Currently open trials in the same condition.
- NCT07224880 — Ellacor® Micro-Coring Technology® in Fitzpatrick Skin Types I-VI, Including Patients Receiving Glucagon-Like Peptide-1 R · recruiting
- NCT06941610 — An Evaluation of the Erchonia Laser As a Non-Invasive Treatment to Improve the Appearance of Skin Laxity · NA · recruiting
- NCT06724510 — Safety and Efficacy Evaluation of High Intensity Focused Ultrasound Device in Eyebrow Lifting · NA · recruiting
- NCT06603194 — Benefit of Bovine or Marine Collagen Vs. Placebo on Skin, Hair, Nails and Whole Body Health in Healthy Adults · NA · recruiting
- NCT06557434 — AV-23-001 AVAVA MIRIA Pilot Study · NA · active not recruiting
Other Sofwave Medical LTD trials
Trials by the same sponsor.
- NCT07094971 — Pure Impact Treatment to Strengthen and Tone Abdomen, Quadriceps and Glutes Muscles · NA · recruiting
- NCT06724146 — Combined Treatment Sofwave and Pure Impact to Strength and Tone Muscles and Improve Lax Skin Appearance · NA · active not recruiting
- NCT06333067 — Treatment to Lift Facial Lax Skin and Improve Facial Wrinkles Using Precise and Lift Applicators · NA · recruiting
- NCT06104514 — Safety and Efficacy of SofWave Treatment to Lift the Upper Lip and Improve the Peri-Oral Rhytids · NA · completed
- NCT05882721 — Treatment for Improvement of Cellulite Appearance Using Form Applicator · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04969380 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sofwave Medical LTD
- Last refreshed: 18 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04969380.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing